Skip to main content
. Author manuscript; available in PMC: 2015 May 11.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Oct 15;21(2):202–224. doi: 10.1016/j.bbmt.2014.10.003

Table 4.

Deferred Late Effects/Quality of Life Trials

Domain Rationale for Deferral
Preventive care Smoking cessation – no preliminary data
Vaccinations – could only be in a limited
number of centers and may not need the
Network
Vitamin D supplementation – appropriate
endpoints unclear
Survivor support Survivorship care plan – ongoing funded
multicenter study
Internet-based survivorship support – ongoing
funded multicenter study (INSPIRE)
Survivorship support package – would require
extensive development
QOL, economics
Late effects
Usually appropriate as secondary endpoints
Cardiotoxicity – need very late follow-up,
expensive study, rare outcome
Sexual dysfunction – lack of preliminary data
Iron overload – unclear clinical implications,
premature for an intervention study
Infertility – lack of a feasible intervention
Avascular necrosis – lack of a feasible
intervention